Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Asset disposition
Director departure

ENZON PHARMACEUTICALS, INC. (ENZN) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/06/2023 8-K Quarterly results
06/15/2022 8-K Quarterly results
06/08/2021 8-K Quarterly results
01/04/2021 8-K Quarterly results
12/21/2020 8-K Submission of Matters to a Vote of Security Holders
10/14/2020 8-K Quarterly results
09/23/2020 8-K Quarterly results
09/15/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Enzon Pharmaceuticals Announces Key Dates for Rights Offering"
09/02/2020 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events, Financial Statements and Exhibits
Docs: "Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting Cranford, New Jersey, September 2, 2020 /GlobeNewswire/ – Enzon Pharmaceuticals, Inc. today announced that its 2020 annual meeting of stockholders originally scheduled to be held on Thursday, September 17, 2020, has been postponed and will now be held on Friday, December 18, 2020. Once determined by the Company’ s Board of Directors, the Company will announce the record date, time and location of the 2020 Annual Meeting. The Company decided to postpone the 2020 Annual Meeting due to timing considerations related to certain corporate actions recently announced by the Company. The Company manages its sources of royalty revenues from existing licensing arrangements with other companies primarily related to sales of cer..."
09/01/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Investment Agreement, by and between Enzon Pharmaceuticals, Inc. and Icahn Capital LP"
08/31/2020 8-K Quarterly results
08/14/2020 8-K Quarterly results
08/07/2020 8-K Quarterly results
08/22/2019 8-K Submission of Matters to a Vote of Security Holders, Other Events
01/31/2019 8-K Quarterly results
08/13/2018 8-K Submission of Matters to a Vote of Security Holders
08/10/2017 8-K Quarterly results
06/30/2017 8-K Form 8-K - Current report
12/08/2016 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
10/26/2016 8-K Form 8-K - Current report
08/09/2016 8-K Other Events
07/05/2016 8-K Submission of Matters to a Vote of Security Holders, Other Events
05/16/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
10/22/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/15/2013 8-K Other Events
10/09/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/01/2013 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
08/12/2013 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of KPMG LLP"
08/09/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/06/2013 8-K Asset disposition
02/28/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Severance Agreement and Release of Claims, by and between Aby Buchbinder and Enzon Pharmaceuticals, Inc"
02/12/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment No. 1 to the Second Amended and Restated By-Laws of Enzon Pharmaceuticals, Inc. (effective February 15, 2013)",
"General Severance Agreement, by and between Timothy G. Daly and Enzon Pharmaceuticals, Inc"
11/30/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Enzon Announces Special Dividend"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy